Showing 3201-3210 of 4166 results for "".
- Alimera Sciences Launches Iluvien in Germany For Noninfectious Uveitishttps://modernod.com/news/alimera-sciences-launches-iluvien-in-germany-for-noninfectious-uveitis/2476846/Alimera Sciences announced that it will immediately commence the launch of Iluvien in Germany for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye (NIPU). Following the European Union’s Mutual Recognition Procedure in March 2019, Germany is t
- International Congress of Scleral Contacts: A Chance to Advance Your Skillshttps://modernod.com/news/international-congress-of-scleral-contacts-a-chance-to-advance-your-skills/2486922/Given that scleral contact lenses can manage corneal conditions, such as keratoconus, and treat dry eye disease effectively, it makes sense for ODs to be aware of the latest related innovations to continue to meet these patients’ vision and comfort needs. This is where the International Congress
- Prevent Blindness Launches Online Patient Resource on Insurance Benefits for Eye Carehttps://modernod.com/news/prevent-blindness-launches-online-patient-resource-on-insurance-benefits-for-eye-care/2484307/With open enrollment in Medicare and the Affordable Care Act Marketplace underway, Prevent Blindness has launched a new online educational resource to help individuals and families better understand their vision and eye care benefits. According to Prevent Blindness, the new guide, “Understa
- Gen Z Contact Lens Adoption Presents Major Growth Opportunity, New CLI Research Showshttps://modernod.com/news/gen-z-contact-lens-adoption-presents-major-growth-opportunity-new-cli-research-shows/2484147/Fresh consumer data from the Contact Lens Institute (CLI) reveals that eye care professionals have a significant chance to boost contact lens prescribing among Gen Z patients. The findings—unveiled ahead of a main-stage session at Vision Expo West—h
- Neurolens, Maker of Contoured Prism Technology, Rebrands as Newtonhttps://modernod.com/news/neurolens-maker-of-contoured-prism-technology-rebrands-as-newton/2484138/Neurolens announced its official rebrand to Newton. Named in honor of Sir Isaac Newton, the company said the rebrand reflects Newton’s broader vision to build on its foundation of innovative lens technology and continue driving outcomes that help pa
- Sight Sciences Publishes 24-Month SAHARA RCT Results Evaluating TearCare in Dry Eye Diseasehttps://modernod.com/news/sight-sciences-publishes-24-month-sahara-rct-results-evaluating-tearcare-in-dry-eye-disease/2482923/Sight Sciences has published 24-month results from Stage 3 of its landmark SAHARA randomized controlled trial (RCT). The study, published in Optometry and Vision Science, assesses the long-term effi
- Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindnesshttps://modernod.com/news/opus-genetics-and-the-global-rdh12-alliance-partner-to-advance-rdh12-gene-therapy-for-inherited-childhood-blindness/2482902/Opus Genetics announced a partnership with the Global RDH12 Alliance to advance Opus’ gene therapy program for patients with vision loss due to retinol dehydrogenase 12 (RDH12) gene mutations. The Alliance serves as a collaborative platform uniting advocacy groups dedicated to RDH
- Nanoscope Initiates Rolling Submission of BLA to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat RPhttps://modernod.com/news/nanoscope-initiates-rolling-submission-of-bla-to-fda-for-mco-010-the-first-gene-agnostic-therapy-to-treat-rp/2482884/Nanoscope Therapeutics announced the initiation of a rolling submission of a biologics license application (BLA) to the FDA for its lead investigational therapy, MCO-010, for the treatment of severe vision loss due to retinitis pigmentosa (RP). This marks a significant re
- Alcon Receives Health Canada Approval for Unity VCShttps://modernod.com/news/alcons-receives-health-canada-approval-for-unity-vcs/2482882/Alcon announced that Unity Vitreoretinal Cataract System (VCS) has received Health Canada approval. Unity VCS is designed to deliver enhanced workflow efficiencies over Alcon’s current leading systems, Constellation Vision System for vitreoretinal and combined proce
- J&J Launches Daily Disposable Multifocal Toric Contact Lens: Acuvue Oasys Max 1-Day Multifocal for Astigmatismhttps://modernod.com/news/johnson-johnson-launches-daily-disposable-multifocal-toric-contact-lens-acuvue-oasys-max-1-day-multifocal-for-astigmatism/2482858/Johnson & Johnson announced the launch of Acuvue Oasys Max 1-Day Multifocal for Astigmatism, a daily disposable contact lens for people with both astigmatism and presbyopia. The company says this contact lens provides patients crisp, clear, stable vision at all distances and in all